Skip to main content
. 2016 May 25;12(7):850–860. doi: 10.7150/ijbs.14773

Figure 7.

Figure 7

Suppression of galectin-1 resulted in deactivation of the Ras/Raf/ERK pathway with deguelin treatment. (A) Mock- or deguelin-treated cells were lysed for co-immunoprecipitation and then analyzed by western blotting. (B) Galectin-1 overexpression and shGal-1-knockdown cells were incubated with 25μM deguelin for 24 hours, respectively. Cell lysates were harvested and the indicated proteins were determined by western blotting. (C) Galectin-1 overexpression cells with or without L779450 (10μM) were incubated with 25μM deguelin for 24 hours. Flow cytometry was used for cell apoptosis analysis. The data are representatives of three independent experiments and presented as mean±SD. **P<0.01. (D) Galectin-1 overexpression cells with or without L779450 (10μM) were incubated with 25μM deguelin for 24 hours. Then cell lysates were harvested for western blotting.